Schott Pharma AG & Co KGaA
1SXPLife Science Tools
€25.30+0.20%As of Oct 29vs prior close
- Market cap
- $4.2B
- P/E (TTM)
- 28.4×
- P/E (FY1)
- 25.7×
- From 52W high
- −2.69%
- EPS (LTM)
- €0.90
- Revenue (LTM)
- €1B
- Net margin
- 13.40%
Nomior Score
48
Steady ProfileBottom 46% of the scored universe
Growth43
Quality56
Value37
Momentum—
Resilience62
Growth
+6.30%revenue a year over 3 fiscal years
YE22 €821.1MLTM €1B
Connections
Revenue to profitYE25
15% of revenue became net profit, down 1 pt on a year.